• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Event Description
It was clogged up with clots and another physician came in to place the 2nd jada system [device occlusion] she didn¿t think the patient was dilated 3cm, but she said the physician said the patient was dilated 3cm".[wrong technique in device usage process] case narrative: this initial spontaneous report originating from the united states, was received from a company representative via nurse, referring to a female patient of unknown age.The patient¿s current conditions, medical history and concomitant medications were not reported.This report concerns 1 patient and 2 devices.On an unknown date, the patient was started on vacuum-induced hemorrhage control system (jada system #1) (lot# and expiry date were not reported) for unknown indication (product used for unknown indication).It was told by the nurse stated that it was clogged up with clots (device occlusion) and another physician came in to place the second vacuum-induced hemorrhage control system (jada system # 2) (lot# and expiry date were not reported) for unknown indication (product used for unknown indication).The patient did well with the second vacuum-induced hemorrhage control system (jada system # 2) in place (required intervention).The nurse also stated the physician said the patient was dilated 3 centimeters (cm) but she did not think the patient was dilated 3cm (wrong technique in device usage process).The nurse also said the event was not "an adverse event" but "more like user error".The availability of the vacuum-induced hemorrhage control system (jada system) for evaluation was unknown.Upon internal review, the event of "device occlusion" was determined to be serious: required intervention.Medical device reporting criteria: serious injury.(b)(4).
 
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key16014976
MDR Text Key305818843
Report Number3002806821-2022-00026
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 12/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-